Search research articles
Contact Us
Filters
Showing results (91-100 of 102) with videos related to
Page
of 11
Sort By:
Leukemia
|
February 25, 2020
PD-L1/L2 protein levels rapidly increase on monocytes via trogocytosis from tumor cells in classical Hodgkin lymphoma
Masaharu Kawashima, Joaquim Carreras, Hiroshi Higuchi, et al.
Nature Immunology
|
October 24, 2017
Metabolic shift induced by systemic activation of T cells in PD-1-deficient mice perturbs brain monoamines and emotional behavior
Michio Miyajima, Baihao Zhang, Yuki Sugiura, et al.
Science (New York, N.Y.)
|
October 27, 2022
Spermidine activates mitochondrial trifunctional protein and improves antitumor immunity in mice
Muna Al-Habsi, Kenji Chamoto, Ken Matsumoto, et al.
JTO Clinical and Research Reports
|
November 29, 2023
Lack of Association of Plasma Levels of Soluble Programmed Cell Death Protein 1, Programmed Death-Ligand 1, and CTLA-4 With Survival for Stage II to IIIA NSCLC After Complete Resection and Adjuvant Chemotherapy
Junko Tanizaki, Hiroaki Kuroda, Toshihide Yokoyama, et al.
Science Translational Medicine
|
December 14, 2022
Combination bezafibrate and nivolumab treatment of patients with advanced non-small cell lung cancer
Kentaro Tanaka, Kenji Chamoto, Sho Saeki, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 8, 2023
Soluble programmed cell death ligand 1 predicts prognosis for gastric cancer patients treated with nivolumab: Blood-based biomarker analysis for the DELIVER trial
Hisato Kawakami, Yu Sunakawa, Eisuke Inoue, et al.
The Journal of Clinical Investigation
|
April 1, 2024
Soluble immune checkpoint factors reflect exhaustion of antitumor immunity and response to PD-1 blockade
Hidetoshi Hayashi, Kenji Chamoto, Ryusuke Hatae, et al.
Nature
|
November 4, 2021
B cell-derived GABA elicits IL-10<sup>+</sup> macrophages to limit anti-tumour immunity
Baihao Zhang, Alexis Vogelzang, Michio Miyajima, et al.
Nature Medicine
|
June 25, 2026
Metabolic determinants of cancer immunotherapy outcomes identified by plasma profiling
Déborah Suissa, Marine Fidelle, Ella Reich, et al.
Nature Medicine
|
June 29, 2021
Inherited PD-1 deficiency underlies tuberculosis and autoimmunity in a child
Masato Ogishi, Rui Yang, Caner Aytekin, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 102) with videos related to
Sort By:
Page
of 11
Leukemia
|
February 25, 2020
PD-L1/L2 protein levels rapidly increase on monocytes via trogocytosis from tumor cells in classical Hodgkin lymphoma
Masaharu Kawashima, Joaquim Carreras, Hiroshi Higuchi, et al.
Nature Immunology
|
October 24, 2017
Metabolic shift induced by systemic activation of T cells in PD-1-deficient mice perturbs brain monoamines and emotional behavior
Michio Miyajima, Baihao Zhang, Yuki Sugiura, et al.
Science (New York, N.Y.)
|
October 27, 2022
Spermidine activates mitochondrial trifunctional protein and improves antitumor immunity in mice
Muna Al-Habsi, Kenji Chamoto, Ken Matsumoto, et al.
JTO Clinical and Research Reports
|
November 29, 2023
Lack of Association of Plasma Levels of Soluble Programmed Cell Death Protein 1, Programmed Death-Ligand 1, and CTLA-4 With Survival for Stage II to IIIA NSCLC After Complete Resection and Adjuvant Chemotherapy
Junko Tanizaki, Hiroaki Kuroda, Toshihide Yokoyama, et al.
Science Translational Medicine
|
December 14, 2022
Combination bezafibrate and nivolumab treatment of patients with advanced non-small cell lung cancer
Kentaro Tanaka, Kenji Chamoto, Sho Saeki, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 8, 2023
Soluble programmed cell death ligand 1 predicts prognosis for gastric cancer patients treated with nivolumab: Blood-based biomarker analysis for the DELIVER trial
Hisato Kawakami, Yu Sunakawa, Eisuke Inoue, et al.
The Journal of Clinical Investigation
|
April 1, 2024
Soluble immune checkpoint factors reflect exhaustion of antitumor immunity and response to PD-1 blockade
Hidetoshi Hayashi, Kenji Chamoto, Ryusuke Hatae, et al.
Nature
|
November 4, 2021
B cell-derived GABA elicits IL-10<sup>+</sup> macrophages to limit anti-tumour immunity
Baihao Zhang, Alexis Vogelzang, Michio Miyajima, et al.
Nature Medicine
|
June 25, 2026
Metabolic determinants of cancer immunotherapy outcomes identified by plasma profiling
Déborah Suissa, Marine Fidelle, Ella Reich, et al.
Nature Medicine
|
June 29, 2021
Inherited PD-1 deficiency underlies tuberculosis and autoimmunity in a child
Masato Ogishi, Rui Yang, Caner Aytekin, et al.
Page
of 11